跳至主要内容
临床试验/JPRN-UMIN000005310
JPRN-UMIN000005310已完成4 期

A relationship between pharmacokinetics (PK) and the efficacy of infliximab for patients with psoriasis - Pharmacokinetics (PK) and the efficacy of infliximab in psoriasis

Department of Dermatology, Kawasaki Medical School0 个研究点目标入组 10 人开始时间: 2011年4月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with severe infection, active tuberculosis, history of allergy to ingredients of infliximab or to proteins derived from mouse, demyelinating diseases and its past history and congestive heart failure. Carrier of hepatitis B virus. Patients who have a plan of immunization with vaccine.

研究者

发起方
Department of Dermatology, Kawasaki Medical School

相似试验